• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine.

作者信息

Ulhaq Zulvikar Syambani, Soraya Gita Vita, Indriana Kristin

机构信息

Department of Biochemistry, Faculty of Medicine and Health Science, Maulana Malik Ibrahim State Islamic, University of Malang, Malang, East Java, Indonesia.

Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.

出版信息

Indian J Med Microbiol. 2021 Oct-Dec;39(4):562-563. doi: 10.1016/j.ijmmb.2021.05.017. Epub 2021 Jun 4.

DOI:10.1016/j.ijmmb.2021.05.017
PMID:34099338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8176381/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/8176381/925fd8ed4563/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/8176381/925fd8ed4563/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/8176381/925fd8ed4563/gr1_lrg.jpg

相似文献

1
Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine.科兴新冠疫苗全程接种后出现突破性新冠病例。
Indian J Med Microbiol. 2021 Oct-Dec;39(4):562-563. doi: 10.1016/j.ijmmb.2021.05.017. Epub 2021 Jun 4.
2
Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.CoronaVac 疫苗诱导的抗体对 alpha、gamma 和 D614G SARS-CoV-2 变异株的中和作用。
J Med Virol. 2022 Jan;94(1):399-403. doi: 10.1002/jmv.27310. Epub 2021 Sep 8.
3
Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.在系统性红斑狼疮患者中使用异源加强针后，康希诺新冠疫苗的免疫原性、安全性和反应原性：一项病例系列研究。
RMD Open. 2021 Dec;7(3). doi: 10.1136/rmdopen-2021-002019.
4
SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.两剂科兴疫苗接种方案后接种第三剂科兴疫苗或BNT162b2疫苗后的新冠病毒特异性抗体反应。
J Med Virol. 2022 Jan;94(1):39-41. doi: 10.1002/jmv.27350. Epub 2021 Sep 21.
5
Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy.母体接种 SARS-CoV-2 灭活疫苗（科兴）后脐带血抗体。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3484-3486. doi: 10.1080/21645515.2021.1947099. Epub 2021 Jul 30.
6
Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine.灭活 SARS-CoV-2 疫苗诱导的有限且短暂的病毒中和滴度。
Emerg Infect Dis. 2021 Dec;27(12):3178-3180. doi: 10.3201/eid2712.211772. Epub 2021 Sep 24.
7
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.新型冠状病毒（SARS-CoV-2）疫苗的黏膜和血清免疫应答。
Front Immunol. 2021 Oct 12;12:744887. doi: 10.3389/fimmu.2021.744887. eCollection 2021.
8
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.医护人员接种两剂灭活病毒疫苗后的免疫原性：有和无既往 COVID-19 感染的前瞻性观察研究。
J Med Virol. 2022 Jan;94(1):279-286. doi: 10.1002/jmv.27316. Epub 2021 Sep 10.
9
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.新冠病毒（SARS-CoV-2）感染发生在完全接种疫苗很长时间后，与中和抗体缺乏有关。
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115565. doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.
10
Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report.母亲接种科兴疫苗后 COVID-19 抗体的垂直传播：一例报告。
Rev Soc Bras Med Trop. 2021 Nov 12;54:e0385. doi: 10.1590/0037-8682-0385-2021. eCollection 2021.

引用本文的文献

1
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.接种两剂 BBIBP-CorV 疫苗后单剂 Ad26.COV2.S 加强针对成年人 SARS-CoV-2 感染的效果：一项 1/2 期开放标签试验的第 28 天结果。
Vaccine. 2023 Jul 19;41(32):4648-4657. doi: 10.1016/j.vaccine.2023.06.043. Epub 2023 Jun 15.
2
Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses.两剂 mRNA 疫苗接种后出现味觉丧失的有症状 SARS-CoV-2 感染。
Int J Environ Res Public Health. 2022 Jan 13;19(2):886. doi: 10.3390/ijerph19020886.
3
A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization.

本文引用的文献

1
Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.新冠疫情：官员承认中国疫苗可能需要改进以提高效力。
BMJ. 2021 Apr 13;373:n969. doi: 10.1136/bmj.n969.
一种有前景的 COVID-19 疫苗接种策略：异源免疫。
J Microbiol Biotechnol. 2021 Dec 28;31(12):1601-1614. doi: 10.4014/jmb.2111.11026.
4
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.依靠新冠疫苗：洞察当前策略、进展与未来挑战
Biomedicines. 2021 Nov 22;9(11):1740. doi: 10.3390/biomedicines9111740.
5
Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections.SARS-CoV-2 免疫逃逸 Spike 变异对二次感染和疫苗突破感染的影响。
Front Immunol. 2021 Nov 3;12:742167. doi: 10.3389/fimmu.2021.742167. eCollection 2021.
6
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战：对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.